Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05291936 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Two Daily Disposable Toric Soft Contact Lenses Over One Week of Wear
A NA study of Ocular Physiology, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
- 5
- Study locations
NCT05291936: Completed NA study of Ocular Physiology, sponsored by Johnson & Johnson Vision Care.
NCT05291936 is a NA study of Ocular Physiology that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 78 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05291936, a NA study of Ocular Physiology, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a bilateral wear, dispensing, randomized, controlled, double-masked, 2-sequence ×2-period crossover study to evaluate ocular physiology following contact lens wear.
Primary Outcome
Slit Lamp Findings (SLF) were assessed using a biomicroscope and was graded using the FDA grading scale (Grade: 0, 1,2, 3 and 4) with grade 0 represents the absence of findings and 1 to 4 representing successively worse findings (i.e. Grade 1 = trace, Grade 2 = Mild, Grade 3 = moderate and Grade 4 = severe). This was performed on each subject eye at every study visit (baseline, unscheduled visits and 1-week follow-up). The data was then dichotomized into two groups. Those with grade 3 or higher
Conditions Studied
Interventions
- DEVICE PRECISION1® for Astigmatism Contact Lenses
- DEVICE MyDay® Toric Soft Contact Lenses
Study Locations (5)
Florida
- VRC - Jacksonville
- Sabal Eye Care - Longwood
New York
- Sacco Eye Group - Vestal
Ohio
- Professional Vision Care Inc. - Westerville - Westerville
Virginia
- Botetourt Eyecare LLC - Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2022-03-30 |
| Est. Completion | 2022-05-27 |
| Phase | NA |
What the finished NCT05291936 record still lists
NCT05291936 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Ocular Physiology appearing as the primary indexed condition, and to 2 interventions - of which PRECISION1® for Astigmatism Contact Lenses is the first listed.
NCT05291936 lists 5 locations in 4 states (Florida, New York, Ohio).
Frequently Asked Questions
What is clinical trial NCT05291936 about?
NCT05291936 is a clinical study titled "Clinical Evaluation of Two Daily Disposable Toric Soft Contact Lenses Over One Week of Wear". This is a bilateral wear, dispensing, randomized, controlled, double-masked, 2-sequence ×2-period crossover study to evaluate ocular physiology following contact lens wear.
What is the current status of trial NCT05291936?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2022-03-30. Estimated completion is 2022-05-27.
What conditions does trial NCT05291936 study?
This clinical trial studies the following conditions: Ocular Physiology.
What interventions are being tested in trial NCT05291936?
The interventions under investigation include: PRECISION1® for Astigmatism Contact Lenses (DEVICE), MyDay® Toric Soft Contact Lenses (DEVICE).
Who is sponsoring clinical trial NCT05291936?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05291936 being conducted?
This trial has 5 study locations across Florida, New York, Ohio, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ocular Physiology
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05291936's enrollment target sits among peer trials
78 1060th of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI